Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy and Surgical Resection: A SEER-Medicare Analysis

被引：0
|
作者：
Smith, J. K. [1 ]
Ng, S. C. [1 ]
Simons, J. P. [1 ]
Shah, S. A. [1 ]
McDade, T. P. [1 ]
Tseng, J. F. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
PANCREAS | 2010年 / 39卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1348 / 1348
页数：1
相关论文
共 50 条
  • [1] Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis
    Hugar, Lee A.
    Yabes, Jonathan G.
    Turner, Robert M., II
    Fam, Mina M.
    Appleman, Leonard J.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    [J]. UROLOGY, 2019, 124 : 191 - 197
  • [2] Re: Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis
    Griebling, Tomas L.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (02): : 363 - 363
  • [3] Postoperative Mortality Following Multi-Modality Therapy for Pancreatic Cancer: Analysis of the SEER-Medicare Data
    Nayar, Preethy
    Chandak, Aastha
    Gupta, Niodita
    Yu, Fang
    Qiu, Fang
    Ganti, Apar Kishor
    Are, Chandrakanth
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (02) : 158 - 163
  • [4] Nomogram for Predicting the Benefit of Neoadjuvant Chemoradiotherapy for Patients With Esophageal Cancer A SEER-Medicare Analysis
    Eil, Robert
    Diggs, Brian S.
    Wang, Samuel J.
    Dolan, James P.
    Hunter, John G.
    Thomas, Charles R.
    [J]. CANCER, 2014, 120 (04) : 492 - 498
  • [5] Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
    Gemenetzis, Georgios
    Groot, Vincent P.
    Blair, Alex B.
    Laheru, Daniel A.
    Zheng, Lei
    Narang, Amol K.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Yu, Jun
    Burkhart, Richard A.
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    [J]. ANNALS OF SURGERY, 2019, 270 (02) : 340 - 347
  • [6] Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for esophageal cancer: A SEER-Medicare analysis.
    Eil, Robert
    Diggs, Brian S.
    Wang, Samuel J.
    Dolan, James P.
    Hunter, John G.
    Thomas, Charles R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Validation of Pancreatic Cancer Diagnosis Claims Within SEER-Medicare
    Ritchey, Mary E.
    He, Jinghua
    Engel, Samuel S.
    Yong, Mellissa
    Brodovicz, Kimberly G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 24 - 24
  • [8] Impact of Preoperative MRI on the Surgical Treatment of Breast Cancer: A SEER-Medicare Analysis
    Thorsen, C. M.
    Weiss, J. E.
    Kerlikowske, K.
    Ozanne, E. M.
    Buist, D. S.
    Hubbard, R. A.
    Tosteson, A. N.
    Henderson, L. M.
    Virnig, B. A.
    Goodrich, M. E.
    Onega, T. L.
    [J]. CANCER RESEARCH, 2012, 72
  • [9] Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis of SEER-Medicare Database
    Parikh, Neehar D.
    Marshall, Vincent D.
    Nathan, Hari
    Balkrishnan, Rajesh
    Shahinian, Vahakn
    [J]. HEPATOLOGY, 2015, 62 : 409A - 410A
  • [10] One year mortality following pancreatectomy for pancreatic cancer: analysis of the SEER-Medicare data
    Nayar, Preethy
    Are, Chandrakanth
    Yu, Fang
    Chandak, Aastha N.
    Gupta, Niodita
    [J]. CANCER RESEARCH, 2015, 75
12345